Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

Inhibition of human immunodeficiency virus (HIV) infection in vitro by anticarbohydrate monoclonal antibodies: peripheral glycosylation of HIV envelope glycoprotein gp120 may be a target for virus neutralization.

Research output: Contribution to journalJournal articleResearch

  1. Replicons of a rodent hepatitis C model virus permit selection of highly permissive cells

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. IDENTIFICATION OF PIPERAZINYLBENZENESULFONAMIDES AS NEW INHIBITORS OF CLAUDIN-1 TRAFFICKING AND HEPATITIS C VIRUS ENTRY

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. Primary resistance to integrase strand-transfer inhibitors in Europe

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Why START? Reflections that led to the conduct of this large long-term strategic HIV trial

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Risk of HIV or second syphilis infection in Danish men with newly acquired syphilis in the period 2000-2010

    Research output: Contribution to journalJournal articleResearchpeer-review

View graph of relations
Carbohydrate structures are often involved in the initial adhesion of pathogens to target cells. In the present study, a panel of anticarbohydrate monoclonal antibodies (MAbs) was tested for their ability to inhibit in vitro human immunodeficiency virus infectivity. MAbs against three different N- and O-linked carbohydrate epitopes (LeY, A1, and sialyl-Tn) were able to block infection by cell-free virus as well as inhibit syncytium formation. Inhibition of virus infectivity was independent of virus strain (HTLVIIIB or patient isolate SSI-002), the cell line used for virus propagation (H9 or MT4), and the cell type used as the infection target (MT4, PMC, or selected T4 lymphocytes). Inhibition was observed when viruses were preincubated with MAbs but not when cells were preincubated with MAbs before inoculation, and the MAbs were shown to precipitate 125I-labeled gp120. The MAbs therefore define carbohydrate structures expressed by the viral envelope glycoprotein gp120, indicating that glycans of the viral envelope are possible targets for immunotherapy or vaccine development or both.
Translated title of the contributionInhibition of human immunodeficiency virus (HIV) infection in vitro by anticarbohydrate monoclonal antibodies: peripheral glycosylation of HIV envelope glycoprotein gp120 may be a target for virus neutralization.
Original languageEnglish
JournalJournal of Virology
Volume64
Issue number6
Pages (from-to)2833-2840
Number of pages8
ISSN0022-538X
Publication statusPublished - 1990

ID: 32506195